Scorpius Holdings Inc. has received a Notice of Public Disposition from its collateral agent, indicating that due to multiple defaults on its secured notes, the company's assets will be sold at a public sale. The sale, scheduled for November 12, 2025, may occur in-person at the offices of SC&H Capital in Columbia, Maryland, or remotely via video platform. The collateral to be sold includes all personal property and assets of Scorpius Holdings and its subsidiaries, notably the company's significant stakes in Scorpius Biomanufacturing, Inc. and Skunkworx Bio, Inc. The secured notes currently represent obligations exceeding $26 million.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Scorpius Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001079973-25-001626), on October 21, 2025, and is solely responsible for the information contained therein.